INCOME STATEMENT (Quarterly GAAP In millions $) |
(Aug 31 2023) II. Quarter |
(May 31 2023) I. Quarter |
(Feb 28 2023) IV. Quarter |
(Nov 30 2022) III. Quarter |
(Aug 31 2022) II. Quarter |
Unrealized Gain Loss On Derivatives |
- |
- |
|
- |
0.00 |
Revenue From Contract With Customer Including Assessed Tax |
0.39 |
0.39 |
|
0.40 |
0.27 |
Revenue From Contract With Customer Including Assessed Tax |
- |
- |
|
- |
- |
Increase Decrease In Accounts Payable |
- |
- |
|
- |
- |
Loss On Debt Covenant Violation |
- |
- |
|
- |
- |
Derivative Gain Loss On Derivative Net |
- |
- |
|
- |
- |
Other Revenue |
0.00 |
0.00 |
|
0.00 |
0.00 |
Total Revenue |
0.39 |
0.39 |
0.28 |
0.40 |
0.27 |
Cost of Revenue |
0.09 |
0.09 |
0.22 |
0.13 |
0.03 |
Gross
Profit |
0.30 |
0.29 |
0.05 |
0.28 |
0.23 |
Selling, Administration, Marketing |
2.29 |
2.12 |
2.22 |
2.12 |
2.24 |
Depriciation & Amortization |
0.19 |
0.17 |
0.15 |
0.09 |
0.15 |
Research and Development Expense |
0.79 |
0.89 |
0.82 |
0.81 |
0.96 |
Restructuring, Accretion & impairment charges |
0.04 |
- |
- |
- |
0.00 |
Other operatinig exp. /-income |
0.02 |
0.06 |
0.07 |
0.06 |
0.06 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
3.43 |
3.33 |
3.48 |
3.22 |
3.45 |
Operating income/-loss
|
-3.05 |
-2.95 |
-3.20 |
-2.81 |
-3.18 |
Other Deductions / - Income |
Interest expense |
1.75 |
1.61 |
1.98 |
1.27 |
1.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
1.75 |
1.61 |
1.98 |
1.27 |
1.00 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.04 |
0.00 |
0.00 |
0.00 |
-0.01 |
Total costs & expenses |
5.15 |
4.94 |
5.46 |
4.49 |
4.44 |
Income /-loss before income taxes |
-4.76 |
-4.56 |
-5.18 |
-4.09 |
-4.17 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-4.76 |
-4.56 |
-5.18 |
-4.09 |
-4.17 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-4.76 |
-4.56 |
-5.18 |
-4.09 |
-4.17 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-4.76 |
-4.56 |
-5.18 |
-4.09 |
-4.17 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-4.76 |
-4.56 |
-5.18 |
-4.09 |
-4.17 |
EBIT |
-3.01 |
-2.95 |
-3.20 |
-2.81 |
-3.17 |
EBITD |
-2.82 |
-2.78 |
-3.06 |
-2.72 |
-3.03 |
EBITDA |
-2.11 |
-2.22 |
-2.17 |
-2.30 |
-2.77 |